EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access

Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial

Christopher J DeFrancesco, Julia F Reichel, Ejiro Gbaje, Marko Popovic, Carrie Freeman, Marisa Wong, Danya DeMeo, Jiabin Liu, Alejandro Gonzalez Della Valle, Amar Ranawat, Michael Cross, Peter K Sculco und 18 weitere

British Journal of Anaesthesia · 2023-02 · 130 (2) · 234-241

DOI: 10.1016/j.bja.2022.11.003 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2023-02. Verfasst von Christopher J DeFrancesco und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Arthroplasty, Replacement, Knee, Antifibrinolytic Agents, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health, National Center for Advancing Translational Sciences, Hospital for Special Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tranexamic acid (TXA) reduces rates of blood transfusion for total hip arthroplasty (THA) and total knee arthroplasty (TKA). Although the use of oral TXA rather than intravenous (i.v.) TXA might improve safety and reduce cost, it is not clear whether oral administration is as effective. METHODS: This noninferiority trial randomly assigned consecutive patients undergoing primary THA or TKA under neuraxial anaesthesia to either one preoperative dose of oral TXA or one preoperative dose of i.v. TXA. The primary outcome was calculated blood loss on postoperative day 1. Secondary outcomes were transfusions and complications within 30 days of surgery. RESULTS: Four hundred participants were randomised (200 THA and 200 TKA). The final analysis included 196 THA patients (98 oral, 98 i.v.) and 191 TKA patients (93 oral, 98 i.v.). Oral TXA was non-inferior to i.v. TXA in terms of calculated blood loss for both THA (effect size=-18.2 ml; 95% confidence interval [CI], -113 to 76.3; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidArthroplasty, Replacement, KneeAntifibrinolytic AgentsArthroplasty, Replacement, HipHumansBlood Loss, SurgicalAdministration, Intravenous

Stichwörter der Autor:innen

bleedingblood losscomplicationscost effectivenesstotal hip arthroplastytotal knee arthroplastytranexamic acidtransfusion

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA.
  • Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, NY, USA.
  • Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, NY, USA; Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
  • OrthoIndy Hospital, Indianapolis, IN, USA.
  • Department of Rheumatology, Hospital for Special Surgery, New York, NY, USA.
  • Pharmacy Department, Hospital for Special Surgery, New York, NY, USA.

Förderung

  • National Institutes of Health
  • National Center for Advancing Translational Sciences
  • Hospital for Special Surgery

Zitieren

APA

DeFrancesco, C. J., Reichel, J. F., Gbaje, E., Popovic, M., Freeman, C., Wong, M., DeMeo, D., Liu, J., Gonzalez Della Valle, A., Ranawat, A., Cross, M., Sculco, P. K., Haskins, S., Kim, D., Maalouf, D., Kirksey, M., Jules-Elysee, K., Soffin, E. M., Kumar, K., …, & Memtsoudis, S. G. (2023). Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial. British Journal of Anaesthesia, 130(2), 234-241. https://doi.org/10.1016/j.bja.2022.11.003

Vancouver

DeFrancesco CJ, Reichel JF, Gbaje E, Popovic M, Freeman C, Wong M, et al. Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial. British Journal of Anaesthesia. 2023;130(2):234-241. doi:10.1016/j.bja.2022.11.003

BibTeX
@article{DeFrancesco2023,
  author = {DeFrancesco, Christopher J and Reichel, Julia F and Gbaje, Ejiro and Popovic, Marko and Freeman, Carrie and Wong, Marisa and DeMeo, Danya and Liu, Jiabin and Gonzalez Della Valle, Alejandro and Ranawat, Amar and Cross, Michael and Sculco, Peter K and Haskins, Stephen and Kim, David and Maalouf, Daniel and Kirksey, Meghan and Jules-Elysee, Kethy and Soffin, Ellen M and Kumar, Kanupriya and Beathe, Jonathan and Figgie, Mark and Inglis, Allan and Garvin, Sean and Alexiades, Michael and DelPizzo, Kathryn and Russell, Linda A and Sideris, Alexandra and Saleh, Jawad and Zhong, Haoyan and Memtsoudis, Stavros G},
  title = {Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial},
  journal = {British Journal of Anaesthesia},
  year = {2023},
  volume = {130},
  number = {2},
  pages = {234--241},
  doi = {10.1016/j.bja.2022.11.003}
}
Kostenlos starten →